rs1131690838
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1PS1_ModeratePM2PP5_Moderate
The NM_144997.7(FLCN):c.3del(p.Met1?) variant causes a frameshift, start lost change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 33)
Consequence
FLCN
NM_144997.7 frameshift, start_lost
NM_144997.7 frameshift, start_lost
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.31
Genes affected
FLCN (HGNC:27310): (folliculin) This gene is located within the Smith-Magenis syndrome region on chromosome 17. Mutations in this gene are associated with Birt-Hogg-Dube syndrome, which is characterized by fibrofolliculomas, renal tumors, lung cysts, and pneumothorax. Alternative splicing of this gene results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant located near the start codon (<100nt), not predicted to undergo nonsense mediated mRNA decay. There are 73 pathogenic variants in the truncated region.
PS1
Another start lost variant in NM_144997.7 (FLCN) was described as [Likely_pathogenic] in Lovd
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-17228134-TC-T is Pathogenic according to our data. Variant chr17-17228134-TC-T is described in ClinVar as [Pathogenic]. Clinvar id is 428655.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr17-17228134-TC-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FLCN | NM_144997.7 | c.3del | p.Met1? | frameshift_variant, start_lost | 4/14 | ENST00000285071.9 | NP_659434.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FLCN | ENST00000285071.9 | c.3del | p.Met1? | frameshift_variant, start_lost | 4/14 | 1 | NM_144997.7 | ENSP00000285071 | P1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 23, 2018 | The c.3delG pathogenic mutation, located in coding exon 1 of the FLCN gene, results from a deletion of one nucleotide at position 3, causing a translational frameshift with a predicted alternate stop codon (p.M1Ifs*52). This pathogenic mutation has been identified in multiple Birt-Hogg-Dube syndrome (BHDS) families with several individuals who have a history of spontaneous pneumothorax and/or multiple characteristic skin lesions, including pathologically confirmed fibrofolliculomas (Bessis D et al. Br J Dermatol. 2006 Nov;155(5):1067-9; Kluger N et al. Br J Dermatol. 2010 Mar;162(3):527-37). Of note, this alteration may be referred to as c.458delG in some literature. In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at